DLD-1 Colorectal Adenocarcinoma SIRT1 Knock Out Cell Line (DLD-1 SIRT1 KO) from KERAFAST, INC.

Search, find, compare suppliers for DLD-1 Colorectal Adenocarcinoma SIRT1 Knock Out Cell Line (DLD-1 SIRT1 KO) products.

Edit 
Product NameDLD-1 Colorectal Adenocarcinoma SIRT1 Knock Out Cell Line (DLD-1 SIRT1 KO)
DescriptionSource: Human Colon. Cell type: Human colorectal adenocarcinoma cell.
Size1 vial
Concentrationn/a
Applicationsn/a
Other Namesn/a
Gene, Accession, CAS #Accession: Q96EB6
Catalog #ENH130-FP
Price$548
Order / More InfoDLD-1 Colorectal Adenocarcinoma SIRT1 Knock Out Cell Line (DLD-1 SIRT1 KO) from KERAFAST, INC.
Product Specific References
  1. Ren NSX, Ji M, Tokar EJ, Busch EL, Xu X, Lewis D, Li X, Jin A, Zhang Y, WuWKK, Huang W, Li L, Fargo DC, Keku TO, Sandler RS, Li X. Haploinsufficiency ofSIRT1 Enhances Glutamine Metabolism and Promotes Cancer Development. Curr Biol.2017 Feb 20;27(4):483-494.
  2. Chen TR, Hay RJ, Macy ML. Intercellular karyotypic similarity in near-diploid cell lines of human tumor origins. Cancer Genet Cytogenet. 1983 Dec;10(4):351-62.PubMed PMID: 6652615.
  3. Chen TR, Dorotinsky CS, McGuire LJ, Macy ML, Hay RJ. DLD-1 and HCT-15 celllines derived separately from colorectal carcinomas have totally differentchromosome changes but the same genetic origin. Cancer Genet Cytogenet. 1995Jun;81(2):103-8. PubMed PMID: 7621404.
  4. Trainer DL, Kline T, McCabe FL, Faucette LF, Feild J, Chaikin M, Anzano M,Rieman D, Hoffstein S, Li DJ, et al. Biological characterization and oncogeneexpression in human colorectal carcinoma cell lines. Int J Cancer. 1988 Feb15;41(2):287-96. PubMed PMID: 3338874.
  5. Dexter DL, Barbosa JA, Calabresi P. N,N-dimethylformamide-induced alterationof cell culture characteristics and loss of tumorigenicity in cultured humancolon carcinoma cells. Cancer Res. 1979 Mar;39(3):1020-5. PubMed PMID: 427742.
  6. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP. p53mutations in colorectal cancer. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7555-9.PubMed PMID: 1699228; PubMed Central PMCID: PMC54786.
  7. Keesee SK, Meneghini MD, Szaro RP, Wu YJ. Nuclear matrix proteins in humancolon cancer. Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1913-6. PubMed PMID:8127905; PubMed Central PMCID: PMC43274.
  8. Vermeulen SJ, Chen TR, Speleman F, Nollet F, Van Roy FM, Mareel MM. Did thefour human cancer cell lines DLD-1, HCT-15, HCT-8, and HRT-18 originate from one and the same patient? Cancer Genet Cytogenet. 1998 Nov;107(1):76-9. PubMed PMID: 9809040.
  9. Kutchera W, et al. Protaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA 93: 4816-4820, 1996. PubMed: 8643486
KERAFAST, INC.
KERAFAST, INC.
KERAFAST, INC.
An Absolute Biotech Company
2 Shaker Road, Unit B101
Shirley MA 01464
P: +1-617-336-3228
P: +1-800-546-1760
F: +1-866-727-9826

info@kerafast.com
Tech Support: TechnicalSupport@kerafast.com

https://www.kerafast.com

Profile of KERAFAST, INC.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.